Keywords: fda, approves, 30-min, onset, novartis, focalin, xr

FDA approves 30-min onset for Novartis' Focalin XR

Article | 01 December 2008

Print This

The US Food and Drug Administration has approved a 30-minute onset of action for Swiss drug major Novartis' Focalin XR ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in